Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 1
1954 2
1956 1
1957 1
1959 1
1960 1
1962 5
1963 6
1964 4
1965 6
1966 3
1967 4
1969 2
1971 5
1972 1
1982 2
1983 4
1984 5
1985 2
1986 1
1987 3
1988 4
1989 4
1991 1
1995 1
1996 2
1997 1
1998 2
1999 2
2000 2
2001 5
2002 5
2003 3
2004 4
2005 4
2006 2
2007 4
2008 8
2009 11
2010 9
2011 17
2012 32
2013 22
2014 28
2015 51
2016 48
2017 40
2018 47
2019 17
2020 27
2021 34
2022 29
2023 27
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

534 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for A. meoni
Search for A. Moeni instead (3 results)
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
COVID-19 and Parkinsonism: A Critical Appraisal.
Cavallieri F, Fioravanti V, Bove F, Del Prete E, Meoni S, Grisanti S, Zedde M, Pascarella R, Moro E, Valzania F. Cavallieri F, et al. Biomolecules. 2022 Jul 11;12(7):970. doi: 10.3390/biom12070970. Biomolecules. 2022. PMID: 35883526 Free PMC article. Review.
Fingerprinting and profiling in metabolomics of biosamples.
Ghini V, Meoni G, Vignoli A, Di Cesare F, Tenori L, Turano P, Luchinat C. Ghini V, et al. Prog Nucl Magn Reson Spectrosc. 2023 Nov-Dec;138-139:105-135. doi: 10.1016/j.pnmrs.2023.10.002. Epub 2023 Oct 18. Prog Nucl Magn Reson Spectrosc. 2023. PMID: 38065666 Review.
Teleneurology in the COVID–19 era.
Moro E, Meoni S. Moro E, et al. In: Priori A, editor. NEUROLOGY OF COVID–19 [Internet]. Milano: Milano University Press; 2021 Feb. Chapter 15. In: Priori A, editor. NEUROLOGY OF COVID–19 [Internet]. Milano: Milano University Press; 2021 Feb. Chapter 15. PMID: 35507707 Free Books & Documents. Review. No abstract available.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
High-Throughput Metabolomics by 1D NMR.
Vignoli A, Ghini V, Meoni G, Licari C, Takis PG, Tenori L, Turano P, Luchinat C. Vignoli A, et al. Angew Chem Int Ed Engl. 2019 Jan 21;58(4):968-994. doi: 10.1002/anie.201804736. Epub 2018 Nov 11. Angew Chem Int Ed Engl. 2019. PMID: 29999221 Free PMC article. Review.
Pseudoprogression in lung cancer: a case report.
Meoni G, Decarli NL, Benucci M, Raspanti C, Ribecco AS. Meoni G, et al. Explor Target Antitumor Ther. 2020;1(5):372-380. doi: 10.37349/etat.2020.00022. Epub 2020 Oct 30. Explor Target Antitumor Ther. 2020. PMID: 36046488 Free PMC article.
Sex differences in movement disorders.
Meoni S, Macerollo A, Moro E. Meoni S, et al. Nat Rev Neurol. 2020 Feb;16(2):84-96. doi: 10.1038/s41582-019-0294-x. Epub 2020 Jan 3. Nat Rev Neurol. 2020. PMID: 31900464 Review.
Observation of Single-Top-Quark Production in Association with a Photon Using the ATLAS Detector.
Aad G, Abbott B, Abbott DC, Abeling K, Abidi SH, Aboulhorma A, Abramowicz H, Abreu H, Abulaiti Y, Abusleme Hoffman AC, Acharya BS, Achkar B, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Addepalli SV, Adelman J, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agaras MN, Agarwala J, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmad A, Ahmadov F, Ahmed WS, Ahuja S, Ai X, Aielli G, Aizenberg I, Akbiyik M, Åkesson TPA, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Albicocco P, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Ali S, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Amelung C, Ames CG, Amidei D, Amor Dos Santos SP, Amoroso S, Amos KR, Amrouche CS, Ananiev V, Anastopoulos C, Andari N, Andeen T, Anders JK, Andrean SY, Andreazza A, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Appelt C, Aranzabal N, Araujo Ferraz V, Arcangeletti C, Arce ATH, A… See abstract for full author list ➔ Aad G, et al. Phys Rev Lett. 2023 Nov 3;131(18):181901. doi: 10.1103/PhysRevLett.131.181901. Phys Rev Lett. 2023. PMID: 37977601 Free article.
534 results